Posted inStock
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
(Reuters) – Gilead Sciences (NASDAQ:GILD) said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases. The Danish company…